Εμφάνιση απλής εγγραφής

dc.creatorVemmos K., Boubouchairopoulou N., Stafylas P., Vitsou E., Giannakoulas G., Ntaios G., Milionis H., Hahalis G., Parthenakis F., Tsioufis K.en
dc.date.accessioned2023-01-31T10:31:42Z
dc.date.available2023-01-31T10:31:42Z
dc.date.issued2022
dc.identifier10.1080/14737167.2021.1979961
dc.identifier.issn14737167
dc.identifier.urihttp://hdl.handle.net/11615/80570
dc.description.abstractBackground: Stroke is aleading cause of death and disability, with atrial fibrillation (AF) being among key risk factors and AF-related stroke inflicting significant burden on healthcare systems and society. The present study was undertaken for estimating the total annual socioeconomic burden of AF-related stroke in Greece and identifying the key cost contributors. Research design and methods: A cost-of-illness model was developed for estimating the total annual economic burden of AF-related stroke in Greece, from asocietal perspective (year 2018). Atargeted literature review and an advisory board consisting of key experts in the management of AF and AF-related stroke were performed for collecting local resource use and epidemiological data. Results: The total annual socioeconomic burden of AF-related stroke was estimated at €175million, in 2018. Direct and indirect costs accounted for 59% and 41%, respectively. Main contributors were informal care (21.1%), patients’ productivity losses (19.7%) and hospitalizations (15.0%), accounting for more than half of the total costs of AF-related stroke events. Conclusion: A F-related stroke imposes asignificant socioeconomic burden in Greece. Despite results relying on estimations, it seems that ensuring efficient reallocation of resources in appropriate prevention and early intervention strategies could decrease AF-related stroke’s burden but also enhance healthcare systems’ efficiency. Abbreviations: AF=atrial fibrillation. © 2021 Informa UK Limited, trading as Taylor & Francis Group.en
dc.language.isoenen
dc.sourceExpert Review of Pharmacoeconomics and Outcomes Researchen
dc.source.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85115772046&doi=10.1080%2f14737167.2021.1979961&partnerID=40&md5=3e48dea171147753d68f59652faa22c8
dc.subjectanticoagulant agenten
dc.subjectanticoagulant agenten
dc.subjectabsenteeismen
dc.subjectArticleen
dc.subjectatrial fibrillationen
dc.subjectcaregiveren
dc.subjectcerebrovascular accidenten
dc.subjectcost of illnessen
dc.subjectdrug costen
dc.subjectGreeceen
dc.subjecthealth care costen
dc.subjecthospitalization costen
dc.subjecthumanen
dc.subjectpremature mortalityen
dc.subjectatrial fibrillationen
dc.subjectcerebrovascular accidenten
dc.subjecthospitalizationen
dc.subjectAnticoagulantsen
dc.subjectAtrial Fibrillationen
dc.subjectFinancial Stressen
dc.subjectGreeceen
dc.subjectHospitalizationen
dc.subjectHumansen
dc.subjectStrokeen
dc.subjectTaylor and Francis Ltd.en
dc.titleEstimation of the economic burden of atrial fibrillation-related stroke in Greeceen
dc.typejournalArticleen


Αρχεία σε αυτό το τεκμήριο

ΑρχείαΜέγεθοςΤύποςΠροβολή

Δεν υπάρχουν αρχεία που να σχετίζονται με αυτό το τεκμήριο.

Αυτό το τεκμήριο εμφανίζεται στις ακόλουθες συλλογές

Εμφάνιση απλής εγγραφής